A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
Phase
N/ASpan
153 weeksSponsor
Janssen-Cilag Ltd.Gladenbach
Recruiting
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
Phase
N/ASpan
105 weeksSponsor
Hoffmann-La RocheGladenbach
Recruiting
1-2 of 2